During the past decade, Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken" are "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken" in a lesser frequency.

Most popular intervention types in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (6 trials), "Avonex" (1 trials), "Fenebrutinib" (1 trials), "Placebo" (1 trials) and "Placebo matched to fenebrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aarhus Universitetshospital, Neurologisk Afd. F, Skleroseklinikken, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".